224 related articles for article (PubMed ID: 15073090)
1. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms.
Li Y; Zimmermann B; Rusterholz C; Kang A; Holzgreve W; Hahn S
Clin Chem; 2004 Jun; 50(6):1002-11. PubMed ID: 15073090
[TBL] [Abstract][Full Text] [Related]
2. Multiplex fluorescent PCR for noninvasive prenatal detection of fetal-derived paternally inherited diseases using circulatory fetal DNA in maternal plasma.
Tang DL; Li Y; Zhou X; Li X; Zheng F
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):35-9. PubMed ID: 19285775
[TBL] [Abstract][Full Text] [Related]
3. Quantification of fetal and total circulatory DNA in maternal plasma samples before and after size fractionation by agarose gel electrophoresis.
Hromadnikova I; Zejskova L; Doucha J; Codl D
DNA Cell Biol; 2006 Nov; 25(11):635-40. PubMed ID: 17132094
[TBL] [Abstract][Full Text] [Related]
4. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations.
Li Y; Holzgreve W; Hahn S
Methods Mol Biol; 2008; 444():239-51. PubMed ID: 18425486
[TBL] [Abstract][Full Text] [Related]
5. Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma.
Ho SS; Barrett A; Thadani H; Asibal CL; Koay ES; Choolani M
Clin Chem Lab Med; 2015 Jul; 53(8):1189-95. PubMed ID: 25581758
[TBL] [Abstract][Full Text] [Related]
6. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma.
Li Y; Di Naro E; Vitucci A; Zimmermann B; Holzgreve W; Hahn S
JAMA; 2005 Feb; 293(7):843-9. PubMed ID: 15713774
[TBL] [Abstract][Full Text] [Related]
7. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation.
Li Y; Wenzel F; Holzgreve W; Hahn S
Electrophoresis; 2006 Oct; 27(19):3889-96. PubMed ID: 16972300
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening of single-gene disorders from maternal blood.
Sekizawa A; Saito H
Am J Pharmacogenomics; 2001; 1(2):111-7. PubMed ID: 12174672
[TBL] [Abstract][Full Text] [Related]
9. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma--case report.
Li Y; Holzgreve W; Page-Christiaens GC; Gille JJ; Hahn S
Prenat Diagn; 2004 Nov; 24(11):896-8. PubMed ID: 15565648
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.
Liao GJ; Chan KC; Jiang P; Sun H; Leung TY; Chiu RW; Lo YM
PLoS One; 2012; 7(5):e38154. PubMed ID: 22666469
[TBL] [Abstract][Full Text] [Related]
11. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
[TBL] [Abstract][Full Text] [Related]
12. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications.
Avent ND; Madgett TE; Maddocks DG; Soothill PW
Curr Opin Obstet Gynecol; 2009 Apr; 21(2):175-9. PubMed ID: 19262379
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite markers within --SEA breakpoints for prenatal diagnosis of HbBarts hydrops fetalis.
Ho SS; Chong SS; Koay ES; Chan YH; Sukumar P; Chiu LL; Wang W; Roy A; Rauff M; Su LL; Biswas A; Choolani M
Clin Chem; 2007 Feb; 53(2):173-9. PubMed ID: 17158194
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in fetal DNA in maternal plasma.
Chiu RW; Lo YM
Ann N Y Acad Sci; 2004 Jun; 1022():100-4. PubMed ID: 15251946
[TBL] [Abstract][Full Text] [Related]
15. Application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis.
Chiu RW; Lo YM
Expert Rev Mol Diagn; 2002 Jan; 2(1):32-40. PubMed ID: 11963800
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation.
Li Y; Hahn S; Holzgreve W
Ann N Y Acad Sci; 2006 Dec; 1092():285-92. PubMed ID: 17308152
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.
Sekizawa A; Purwosunu Y; Matsuoka R; Koide K; Okazaki S; Farina A; Saito H; Okai T
J Obstet Gynaecol Res; 2007 Dec; 33(6):747-64. PubMed ID: 18001438
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma.
Lun FM; Tsui NB; Chan KC; Leung TY; Lau TK; Charoenkwan P; Chow KC; Lo WY; Wanapirak C; Sanguansermsri T; Cantor CR; Chiu RW; Lo YM
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19920-5. PubMed ID: 19060211
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
[TBL] [Abstract][Full Text] [Related]
20. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma.
Poon LL; Leung TN; Lau TK; Chow KC; Lo YM
Clin Chem; 2002 Jan; 48(1):35-41. PubMed ID: 11751536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
